Sapropterin (Dr. Reddy's – April)

May 2024Pharmacy Updates

Dr. Reddy's Laboratories Ltd. has recalled six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg. Sapropterin is used to reduce blood levels of a certain amino acid in people with a rare, inherited disorder called phenylketonuria.

This drug is being recalled because discolored powder was found in it during laboratory testing. It may decrease the effectiveness of the product.

As of April 23, 2024, there had been no reports of adverse events related to this recall.

To learn if your medication was recalled, contact your doctor or the pharmacy where you received the medication, or visit the FDA website below.

Consumers who have Sapropterin Dihydrochloride Powder for Oral Solution 100 mg from a recalled lot should contact their doctor about next steps before stopping use of the product. Recalled medicine should be returned to the place of purchase.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Dr. Reddy's Laboratories at 1-866-733-3952. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care

Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.
Feb. 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Feb. 2026Education/Webinars

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates